Evidence map›Paper›PMID 21659475›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2011

Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP).

Danusa Menegaz, Mathew T Mizwicki, Antonio Barrientos-Duran, Ning Chen, Helen L Henry, Anthony W Norman

Open access · greenAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Vitamin D Receptor Is Necessary for Mitochondrial Function and Cell Health.International journal of molecular sciences · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Effect ofInternational journal of rheumatology · 2017
    Article
  18. Interactions between oestrogen and 1α,25(OH)Basic and clinical andrology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Danusa MenegazDepartment of Biochemistry, University of California, Riverside, California 92521, USA.
Mathew T Mizwicki
Antonio Barrientos-Duran
Ning Chen
Helen L Henry
Anthony W Norman
University of California, Riverside · US

Funding

VITAMIN D AND CALCIUM METABOLISMR01DK009012 · NIDDK · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NORMAN, ANTHONY W. · 1995 to 2008
$3.0M
VITAMIN D AND CALCIUM METABOLISMR37DK009012 · NIDDK · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NORMAN, ANTHONY W. · 1986 to 1994
–
NIDDK NIH HHS DK-09012-048
6 · The paper itself

Abstract

We have postulated that the vitamin D receptor (VDR) contains two overlapping ligand binding sites, a genomic pocket and an alternative pocket (AP), that mediate regulation of gene transcription and rapid responses, respectively. Flexible VDR + ligand docking calculations predict that the major blood metabolite, 25(OH)-vitamin D(3) (25D3), and curcumin (CM) bind more selectively to the VDR-AP when compared with the seco-steroid hormone 1α,25(OH)(2)-vitamin D(3) (1,25D3). In VDR wild-type-transfected COS-1 cells and TM4 Sertoli cells, 1,25D3, 25D3, and CM each trigger voltage-gated, outwardly rectifying chloride channel (ORCC) currents that can be blocked by the VDR antagonist 1β,25(OH)(2)-vitamin D(3) and the chloride channel antagonist (4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid). VDR mutational analysis in transfected COS-1 cells demonstrate the DNA-binding domain is not, but the ligand binding and hinge domains of the VDR are, required for 1,25D3 and 25D3 to activate the ORCC. Dose-response studies demonstrate that 25D3 and 1,25D3 are approximately equipotent in stimulating ORCC rapid responses, whereas 1 nm 1,25D3 was 1000-fold more potent than 25D3 and CM in stimulating gene expression. The VDR-AP agonist effects of 1,25D3, 25D3, and low-dose CM are lost after pretreatment of TM4 cells with VDR small interfering RNA. Collectively, these results are consistent with an essential role for the VDR-AP in initiating the signaling required for rapid opening of ORCC. The fact that 25D3 is equipotent to 1,25D3 in opening ORCC suggests that reconsideration of the ability of 25D3 to generate biological responses in vivo may be in order.

Indexed as

Ion Channel GatingAnimalsBinding SitesCalcifediolChloride ChannelsChlorocebus aethiopsCOS CellsCurcuminDrug SynergismErgosterolGenomeHumansLigandsMaleModels, MolecularProtein Structure, TertiaryCalcifediolChloride ChannelsCurcuminErgosterolLigandsReceptors, Calcitriol

Identifiers

PMID21659475
PMCPMC3146250
OpenAlexW2040429776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.